新闻稿 – 纽约州纽约 – 2023 年 8 月 15 日 – Sichenzia Ross Ference LLP 今天宣布，它代表 Aegis Capital Corp. 参与临床阶段制药公司 SciSparc Ltd. 130 万美元的承销公开发行。基础发行包括 6,500,000 股普通股（或代替普通股的预融资认股权证），向公众发行的价格为每股 0.20 美元（或每张预融资认股权证 …
Additional menu
Sichenzia Ross Ference Carmel LLP
Barrett diapolo
60 Degrees Pharmaceuticals A2Z Cust2Mate Solutions Corp. acquisition applied uv inc. At The Market offering Barry Biggar Blog broker business business combination Calidi Biotherapeutics cannabis law Carmel Milazzo Feil LLP closing bell cmf combination corporate law firm corporate litigation Craft Capital Management LLC D. Boral Capital de-spac Debt direct offering EF Hutton Events finra guide inspire veterinary partners news NYC NYC law firm pa capital markets pa corporate law group pa exchange act reporting compliance matters pa registration statements pa restricted stock beneficial ownership filings pa securities law group pharmaceutical PIPES pr pra capital markets pra corporate law group pra exchange act reporting compliance matters pra mergers acquisitions pra registration statements pra restricted stock beneficial ownership filings pra securities law group press release purchase agreement Qualigen Therapeutics Reg A+ warrant inducement offering Revere Securities Reverse Merger roth capital partners SEC securities securities law firm securities law firm securities lawyers sicheniza ross ference sichenzia ross sichenzia ross ference sichenzia ross ference carmel sichenzia ross ference kesner sichenzia ross friedman ference spac Sponsorshop Sports & Entertainment Law SRFC srff srfk llp srf law transaction transactions-prior 公司法律事務組 證券法
